Trial intelligence / Profile preview

Topical sodium cromoglicate for histamine-induced itch and flare in healthy male volunteers

ISRCTN35671014Phase 2Completed

Sponsor
Hewlett Healthcare
Start
Apr 2000
Modality
Small Molecules
01

Overview

Phase 2 trial of sodium cromoglycate in pruritus (6 arms), sponsored by Hewlett Healthcare. Primary endpoints: Change in severity of itch, Change in area of flare and blood flux and 1 more. Started Apr 2000; status: completed.

02

Drugs

sodium cromoglycate
03

Conditions

pruritus

Beyond the preview

Go deeper on ISRCTN35671014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN35671014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call